Skip to main content
. 2016 Nov 15;8(11):4932–4941.

Figure 1.

Figure 1

Berberine treatment inhibits cell proliferation and upregulates miRNA-22-3p expression in HepG2 cells. A: HepG2 cells were stimulated with 0-200 μM berberine for 0-48 h. Inhibition of cell proliferation by berberine was measured with an MTT assay. B: HepG2 cells stimulated with 100 μM berberine for up to 48 h compared with the untreated control. miRNA-22-3p expression was measured with qRT-PCR and is expressed as fold increases.